Cell-derived nanoparticles generated from cell-based artificial antigen presenting cells allow for the robust and rapid manufacturing of patient T cells.
Year: 2025
Type: article
Source: Cytotherapy
Authors: J. Riley, M. Deng, M. Lai, S. Jiang, H. Kong, V. Cooper, E. Carvalho, M. Gu, D. Nardo, C. Zhang, C. Hanindya, J. Barranco, A. Jain, M.M. Davis
Institution: University of Pennsylvania
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409909522